Abbott Laboratories (ABT) vs Stryker Corporation (SYK)
- Abbott Laboratories ABT 110.08 −3.10%
- Stryker Corporation SYK 324.26 −3.23%
Abbott Laboratories and Stryker Corporation are both Medical Devices companies. Abbott Laboratories is the larger, with a market value of $196.6B against $127.6B — 1.5× the size. Stryker Corporation trades at the lower P/E: 35.3× against 42.3×. Abbott Laboratories grew revenue faster over the last twelve months: 10.0% against 7.87%. Stryker Corporation has the higher net margin (13.8% vs 9.75%) and the higher return on invested capital (9.67% vs 0.00%). Both pay a dividend; Abbott Laboratories yields more (2.22% vs 1.05%). Across the 23 metrics below, Stryker Corporation leads on 13 and Abbott Laboratories on 10.
Valuation
Profitability
| Metric | ABT | SYK | Medical Devices median |
|---|---|---|---|
| Gross margin | 56.94% | 65.34% | 57.76% |
| Operating margin | 13.78% | 20.66% | (15.07%) |
| Net margin | 9.75% | 13.78% | (14.45%) |
| Free cash flow margin | 0.00% | 16.76% | (3.88%) |
| Return on equity | 0.00% | 16.02% | (10.35%) |
| Return on assets | 0.00% | 7.68% | (17.26%) |
| Return on invested capital | 0.00% | 9.67% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack